Beneficial Effects of Donepezil on Vascular Endothelial Dysfunction-Associated Dementia Induced by L-Methionine in Rats

Journal of Health Science

Volumn 55, Issue 2, 2009, Pages 215-225

  Koladiya, Rajeshkumar Ukabhi ^a   Jaggi, Amteshwar Singh ^a   Singh, Nirmal ^a   Sharma, Bhupesh Kumar ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Dementia; Donepezil; Endothelial dysfunction; L methionine; Learning; Memory

Indexed keywords

ACETYLCHOLINESTERASE; ATORVASTATIN; BRAIN ENZYME; DONEPEZIL; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NONHUMAN; OXIDATIVE STRESS; RAT; VASCULAR ENDOTHELIUM;

RATTUS;

EID: 66249119736     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.55.215     Document Type: Article

References (57)

1. Parle, M. and Singh, N. (2007) Reversal of mem- ory deficits by atorvastatin and simvastatin in rats. Yakugaku Zasshi, 127, 1125-1137.
2. Davignon, J. and Ganz, P. (2004) Role of Endothelial Dysfunction in Atherosclerosis. Circulation, 109, 27-32.
3. R. Clarke, MD, R. Collins, et. al. (2000) Homocys- teine and risk of ischemic heart disease and stroke: ameta-analysis. JAMA, 288, 2015-2022.
4. Bottiglieri, T. and Diaz-Arrastia, R. (2005) Hyper- homocysteinemia and cognitive function: more than just a casual link. Am. J. Clin. Nutr., 82, 493-504.
5. Lee, H., Kim, H. J., Kim, J. and Chang, N. (2004) Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia. Brain Res., 996, 139-147.
6. Abahji, T. N., Nill, L., Ide, N., Keller, C., Hoffmann, U. and Weiss, N. (2007) Acute Hy- perhomocysteinemia Induces Microvascular and Macrovascular Endothelial Dysfunction. Arch. Med. Res., 38, 411-416.
7. Corzo, L., Zas, R., Rodríguez, S., Ferńandez-Novoa, L. and Cacabelos, R. (2007) Decreased levels of serum nitric oxide in different forms of dementia. Neurosci. Lett., 420, 263-267.
8. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E. and Gaskell, P. C. (1993) Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science, 26, 921-933.
9. Sharma, B., Singh, N. and Singh, M. (2008) Mod- ulation of celecoxib and streptozotocin-induced ex- perimental dementia of Alzheimer's disease type by pitavastatin and donepezil. J. Psychopharmacol., 22, 162-171.
10. Shah, D. I. and Singh, M. (2007) Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Mol. Cell. Biochem., 295, 65-74.
11. Pieper, G. M. (1997) Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc. Res., 34, 145-156.
12. Shah, D. I. and Singh, M. (2006) Inhibition of protein tyrosine phosphatase improves vascular en- dothelial dysfunction. Vascul. Pharmacol., 44, 177-182.
13. Morris, R. G. M. (1984) Development of a water maze producer for studying spatial learning in the rats. J. Neurosci. Methods, 11, 47-60.
14. Parle, M. and Singh, N. (2004) Animal models for testing memory. Asia Pacific J. Pharmacol., 16, 101-122.
15. Dimitrova, K. R., Degroot, K. W., Pacquing, A. M., Suyderhoud, J. P., Pirovic, E. A., Murno, T. J., Wieneke, J. A., Myers, A. K. and Kim, Y. D. (2002) Estradiol prevents homocysteine induced endothe- lial injury inmalerats. Cardiovasc. Res., 53, 589-596.
16. Sastry, K. V. H., Moudgal, R. P., Mohan, J., Tyagi, J. S. and Rao, G. S. (2002) Spectrophoto- metric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal. Biochem., 306, 79-82.
17. Allain, C. C., Pool, L. S., Chan, C. S. G., Richmound, W. and Paul, C. F. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-475.
18. Ellman, G. L., Courtney, K. D., Valentino, A. and Featherstone, R. M. (1961) A new and rapid colori- metric determination of acetylcholinesterase activ- ity. Biochem. Pharmacol., 7, 88-95.
19. Okhawa, H., Ohishi, N. and Yagi, K. (1979) Assay of lipid peroxides in animals tissue by thiobarbitu- raic acid reaction. Anal. Biochem., 95, 351-358.
20. Beutler, R. G., Duron, O. and Kelly, B. (1963) Re- duced glutathion estimation. J. Lab. Clin. M ed., 61, 82.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with folin-phenol reagent. J. Biol. Chem., 193, 265-275.
22. Packard, M. G., Teather, L. A. and Bazan, N. G. (1996) Effect of intra-striated injections of platelet-activating factor and PAF antagonist BN 52021 on memory. Neurobiol. Learn. Mem., 66, 176-182.
23. Streck, E. L., Bavaresco, C. S., Netto, C. A. and Wyse, A. T. (2004) Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris wa- ter maze task. Behav. Brain Res., 153, 377-381.
24. Baydas, G., Ozer, M., Yasar, A., Tuzcu, M. and Koz, S. T. (2005) Melatonin improves learning and memory performances impaired by hyperhomocys- teinemia in rats. Brain Res., 1046, 187-194.
25. Stefanello, F. M., Monteiro, S. C., Emilene, C. M., Scherer, B. S., Netto, C. A. and Wyse, A. T. S. (2007) Hypermethioninemia Increases Cerebral Acetylcholinesterase Activity and Impairs Memory in Rats. Neurochem. Res., 32, 1868-1874.
26. Dayal, S., Devlin, A. M., McCaw, R. B., Liu, M. L., Arning, E., Bottiglieri, T., Shane, B., Faraci, F. M. and Lentz, S. R. (2005) Cerebral Vascular Dysfunction in Methionine Synthase Deficient Mice. Circulation, 112, 737-744.
27. Tyagi, N., Moshal, K. S., Sen, U., Vacek, T. P., Kumar, M., Hughes, W. M., J r., Kundu, S. and Tyagi, S. C. (2009) H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid. Redox Signal., 11, 25-33.
28. Shastry, S., Moning, L., Tyagi, N., Steed, M. and Tyagi, S. C. (2005) GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemia. J. Cell. Physiol., 205, 422-427.
29. Atkinson, J. (2001) Cerebrovascular structure and dementia: new drug targets. Trends Pharmacol. Sci., 22, 630-635.
30. Zhu, X., Smith, M. A., Honda, K., Aliev, G., Moreira, P. I., Nunomura, A., Casadesus, G., Harris, P. L. R., Siedlak, S. L. and Perry, G. (2007) Vascular oxidative stress in Alzheimer disease. J. Neurol. Sci., 257, 240-246.
31. Gauthier, S. (2001) Alzheimer's disease: current and Future therapeutic perspectives. Prog Neuropsychopharmacol. Biol. Psychiatry, 25, 73-89.
32. Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'emilia, D. M., Rayudu, P. V., Arnelle, D. R. and Stamler, J. S. (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl- D-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A., 94, 5923-5928.
33. Mattson, M. P. and Haberman, F. (2003) Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders. Curr. Med. Chem., 10, 1923-1929.
34. Obeid, R. and Herrmann, W. (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett., 580, 2994-3005.
35. Hirche, F., Schr̈oder, A., Knoth, B., Stang, G. I. and Eder, K. (2006) Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in choles- terol metabolism. Br. J. Nutr., 95, 879-888.
36. Wolozin, B. and Behl, C. (2000) Mechanisms of neurodegenerative disorders: Part 1: protein aggregates. Arch. Neurol., 57, 793-796.
37. Laufs, U., La Fata, V., Plutzky, J. and Liao, J. K. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation, 97, 1129-1135.
38. Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C. and Walsh, K. (2000) The HMG-CoA reductase inhibitor simvas- tatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. M ed., 6, 1004-1010.
39. Milionis, H. J., Papakostas, J., Kakafika, A., Chasiotis, G., Seferiadis, K. and Elisaf, M. S. (2003) Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidaemia. J. Clin. Pharmacol., 43, 825-830.
40. Morita, H., Saito, Y., Ohashi, N., Yoshikawa, M., Katoh, M., Ashida, T., Kurihara, H., Nakamura, T., Kurabayashi, M. and Nagai, R. (2005) Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin. Circ. J., 69, 475-480.
41. Li, L., Cao, D., Kim, H., Lester, R. and Fukuchi, K. (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann. Neurol., 60, 729-739.
42. Parale, G. P., Baheti, N. N., Kulkarni, P. M. and Panchal, N. V. (2006) Effects of atorvastatin on higher functions. Eur. J. Clin. Pharmacol., 62, 259-265.
43. Roensch, J., Crisby, M., Nordberg, A., Xiao, Y., Zhang, L. J. and Guan, Z. Z. (2007) Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochem. Int., 50, 800-806.
44. Zimmermann, M., Gardoni, F. and Di Luca, M. (2005) Molecular rationale for the pharmacological treatment of Alzheimer's disease. Drugs Aging, 22, 27-37.
45. Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowit z., M. A. and Liao, J. K. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG) -CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A., 95, 8880-8885.
46. Valikovics, A. (2007) Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions. Ideggyogy. Sz., 60, 301-310.
47. Liu, J. and Lee, T. J. F. (1999) Mechanism of pre- junctional muscarinic receptor-mediated inhibition of neurogenic vasodilationincerebral arteries. Am. J. Physiol. Heart Circ. Physiol., 276, 194-204.
48. Quinn, A. C., Petros, J. and Vallance, P. (1995) Ni- tric oxide: an endogenous gas. Br. J. Anaesth., 74, 443-451.
49. Arias, E., Gallego-Sandín, S., Villarroya, M., Garća, A. G. and Lopez, M. G. (2005) Un-equal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SHSY5Y Neuroblastoma Cells: Role of Nicotinic Receptors. J. Pharmacol. Exp. Ther., 315, 1346-1353.
50. Bannerman, D. M., Chapman, P. F., Kelly, P. A. T., Butcher, S. P. and Morris, R. G. M. (1994) Inhibition of Nitric Oxide Synthase Does Not Impair Spatial Learning. J. Neurosci., 14, 7415-7424.
51. Kopf, S. R., Benton, R. S., Kalfin, R. and Giovannini, M. G. (2001) NO synthesis inhibition decreases cortical ACh release and impairs retention of a conditioned response. Brain Res., 849, 141-144.
52. Reddy, O. L., Rajeshkaran, K. and Paul, V. (2002) Evidence for an involvement of nitric oxide in memory of shock avoidance task in rats. Indian J. Physiol. Pharmacol., 46, 119-122.
53. Thomas, T. (2000) Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiol. Aging, 21, 343-348.
54. O'Dell, T. J., Hawkins, R. D., Kandel, E. R. and Arancio, O. (1991) Tests of the roles of two dif- fusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U. S. A., 88, 11285-11289.
55. Reid, R. T. and Sabbagh, M. N. (2008) Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro. J. Neural Transm., 115, 1437-1444.
56. Takada-Takatori, Y., Kume, T., Ohgi, Y., Fujii, T., Niidome, T., Sugimoto, H. and Akaike, A. (2008) Mechanisms of alpha7-nicotinic receptor up- regulation and sensitization to donepezil induced by chronic donepezil treatment. Eur. J. Pharmacol., 590, 150-156.
57. Kaasinen, V., NÅgren, K., Järvenpää, T., Roivainen, A., Yu, M., Oikonen, V., Kurki, T. and Rinne, J. O. (2002) Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J. Clin. Psychopharmacol., 22, 615-620.